Arrowhead Pharmaceuticals Inc. buy B. Riley
Start price
14.02.25
/
50%
€18.85
Target price
14.02.26
€36.16
Performance (%)
195.17%
Price
08:43
€55.64
Summary
This prediction is currently active. The BUY prediction by B__Riley for Arrowhead Pharmaceuticals Inc. has seen massive gains of 195.17%. This prediction currently runs until 14.02.26. The prediction end date can be changed by B__Riley at any time. B__Riley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Arrowhead Pharmaceuticals Inc. | -7.065% | -7.065% |
| iShares Core DAX® | 1.644% | 4.865% |
| iShares Nasdaq 100 | 0.747% | 2.923% |
| iShares Nikkei 225® | 2.442% | 6.212% |
| iShares S&P 500 | 0.618% | 2.843% |
Comments by B__Riley for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $38.00 price target on the stock, down previously from $51.00.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by B__Riley for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€21.28
12.08.24
12.08.24
€50.31
12.08.25
12.08.25
-28.88%
13.08.25
13.08.25
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€31.22
20.07.23
20.07.23
€49.32
20.07.24
20.07.24
-17.26%
21.07.24
21.07.24

